Elsamra Sammy E, Theckumparampil Nithin, Garden Bradley, Alom Manaf, Waingankar Nikhil, Leavitt David A, Kreshover Jessica, Schwartz Michael, Kavoussi Louis R, Richstone Lee
The Arthur Smith Institute for Urology , North Shore Long Island Jewish Health System, New Hyde Park, New York.
J Endourol. 2014 Dec;28(12):1455-9. doi: 10.1089/end.2014.0243.
Laparoscopic (LAP) and robot-assisted laparoscopic (RAL) approaches have been applied to ureteroneocystostomies (UNC) although such experience has been limited to a small number of patients and limited follow-up. Herein, we detail our experience with over 100 minimally invasive UNC, the largest such series to date.
All minimally invasive UNC performed at our institution between 1997 and 2013 and all open UNC performed between 2008 and 2013 were identified. Perioperative parameters of relevance were identified and recorded. Chi-squared and ANOVA with post hoc Tukey analysis were performed for all categorical and continuous variables, respectively.
A total of 130 patients met our study criteria. One hundred five underwent the minimally invasive approach (20 RAL and 85 LAP). Mean follow-up duration was 504 days. Patients in the RAL, LAP, and open cohorts were of similar age, gender and laterality distribution, American Society of Anesthesiologists (ASA) score, body-mass index, history of previous abdominal surgery, history of prior treatment for the ureteral lesion, and surgical indication ( Table 1 ). Operative time was similar across all cohorts (235-257 minutes, p=0.123). Estimated blood loss (EBL) was significantly lower in the RAL and LAP cohorts (100 and 150 mL) compared to their open counterparts (300 mL, p=0.001) although a decrease in hematocrit was similar across all groups. Only four intraoperative complications (4.7%) and two (2.4%) conversions to open were identified in the LAP group, without statistical significance. No intraoperative complications or conversions were identified in the RAL or open cohorts. Median length of stay (LOS) was significantly shorter in the minimally invasive cohorts compared to open (p<0.002). Ninety-day readmission rates (18.8-20%), major complications (10-20%), and failure rates (5.9-16%) were highest in the open cohort although without statistical significance.
RAL or LAP UNC is feasible, safe, and comparable to the open technique with some perioperative benefit in EBL, LOS, and stent duration.
腹腔镜(LAP)和机器人辅助腹腔镜(RAL)方法已应用于输尿管膀胱吻合术(UNC),尽管此类经验仅限于少数患者且随访有限。在此,我们详细介绍了我们在100多例微创UNC方面的经验,这是迄今为止最大的此类系列病例。
确定了1997年至2013年间在我们机构进行的所有微创UNC以及2008年至2013年间进行的所有开放UNC。确定并记录了相关的围手术期参数。分别对所有分类变量和连续变量进行卡方检验和方差分析以及事后Tukey分析。
共有130例患者符合我们的研究标准。105例接受了微创方法(20例RAL和85例LAP)。平均随访时间为504天。RAL、LAP和开放手术组的患者在年龄、性别和侧别分布、美国麻醉医师协会(ASA)评分、体重指数、既往腹部手术史、输尿管病变既往治疗史以及手术指征方面相似(表1)。所有组的手术时间相似(235 - 257分钟,p = 0.123)。与开放手术组(300 mL)相比,RAL和LAP组的估计失血量(EBL)显著更低(分别为100 mL和150 mL,p = 0.001),尽管所有组的血细胞比容下降相似。LAP组仅发现4例术中并发症(4.7%)和2例(2.4%)转为开放手术,无统计学意义。RAL或开放手术组未发现术中并发症或转为开放手术的情况。与开放手术组相比,微创组的中位住院时间(LOS)显著更短(p < 0.002)。开放手术组的90天再入院率(18.8 - 20%)、主要并发症发生率(10 - 20%)和失败率(5.9 - 16%)最高,尽管无统计学意义。
RAL或LAP UNC是可行、安全的,并且在EBL、LOS和支架留置时间方面具有一些围手术期优势,与开放技术相当。